Regulation of synaptic inhibition by GABAA receptor trafficking under normal conditions and in neurological and neuropsy

Nerve cells fine-tune their communication by controlling how many receptor proteins sit at their synapses, and this project will map the molecular machinery that does the adjusting. This matters because when that fine-tuning breaks, brain circuits become unstable. The same trafficking mechanisms that dial inhibition up or down in a healthy brain can go awry in epilepsy, stroke, anxiety, Huntington’s disease, substance abuse, depression, Parkinson’s disease, and autism. Current treatments for these conditions often target receptors bluntly, flooding or blocking them everywhere. Understanding how neurons move receptors to and from synapses could reveal more precise intervention points. If successful, this work will produce a mechanistic map of GABAA receptor trafficking—how neurons decide how many inhibitory receptors to deploy, and what goes wrong in disease. That map is fundamental science: it explains a core operating principle of neural circuits. There is no immediate clinical tool here. But similar fundamental work on receptor trafficking has already informed drug development for chronic pain and cardiac arrhythmias. A deeper grasp of these regulatory processes could eventually guide therapies that restore synaptic inhibition selectively, rather than dousing the whole brain with a drug.